Showing results (171-180 of 2,229) with videos related to
Sort By:
Pageof 223
Cancer Biotherapy & Radiopharmaceuticals|April 1, 1996
Radioimmunoscintigraphy of gastric adenocarcinomas with 99mTc-chimeric ccM4 antibodyY Zhang, Q Ma, J Zhao, et al.Cancer Biotherapy & Radiopharmaceuticals|April 1, 1996
186Re-labeled antibodies to p185HER2 as HER2-targeted radioimmunopharmaceutical agents: comparison of physical and biological characteristics with 125I and 131I-labeled counterpartsC E Kotts, F M Su, C Leddy, et al.Cancer Biotherapy & Radiopharmaceuticals|June 1, 1996
Role of cysteine endopeptidases in cancerogenesisM Siewinski, J Gutowicz, A Zarzycki, et al.Cancer Biotherapy & Radiopharmaceuticals|June 1, 1996
Flavonoid-mediated tumor growth suppression demonstrated by in vivo studyH Kamei, T Koide, T Kojimam, et al.Cancer Biotherapy & Radiopharmaceuticals|August 1, 1996
Alpha interferon-2b, leucovorin, and 5-fluorouracil (ALF) in non-small cell lung cancerW D Quan, R Casal, M Rosenfeld, et al.Cancer Biotherapy & Radiopharmaceuticals|August 1, 1996
Positron emission tomography using [18F]fluorotamoxifen to evaluate therapeutic responses in patients with breast cancer: preliminary studyT Inoue, E E Kim, S Wallace, et al.Cancer Biotherapy & Radiopharmaceuticals|October 21, 2000
Antibody therapy of acute myelogenous leukemiaJ G JurcicCancer Biotherapy & Radiopharmaceuticals|October 21, 2000
Scintigraphic detection of multidrug resistance in cancerS Del Vecchio, A Ciarmiello, M SalvatoreCancer Biotherapy & Radiopharmaceuticals|October 21, 2000
In vitro comparison of sestamibi, tetrofosmin, and furifosmin as agents for functional imaging of multidrug resistance in tumorsT Muzzammil, M J Moore, J R BallingerCancer Biotherapy & Radiopharmaceuticals|October 21, 2000
Tumor-absorbed-dose estimates versus response in tositumomab therapy of previously untreated patients with follicular non-Hodgkin's lymphoma: preliminary reportK F Koral, Y Dewaraja, L A Clarke, et al.Pageof 223